TY - JOUR AU - Walker, A. J. AU - Card, T. R. AU - West, J. AU - Crooks, C. AU - Grainge, M. J. PY - 2013 DA - 2013// TI - Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases JO - Eur J Cancer VL - 49 ID - Walker2013 ER - TY - JOUR AU - Cronin-Fenton, D. P. AU - Sondergaard, F. AU - Pedersen, L. A. AU - Fryzek, J. P. AU - Cetin, K. AU - Acquavella, J. PY - 2010 DA - 2010// TI - Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006 JO - Br J Cancer VL - 103 ID - Cronin-Fenton2010 ER - TY - JOUR AU - Kirwan, C. C. AU - McDowell, G. AU - McCollum, C. N. AU - Kumar, S. AU - Byrne, G. J. PY - 2008 DA - 2008// TI - Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer JO - Br J Cancer VL - 99 ID - Kirwan2008 ER - TY - JOUR AU - Jones, A. AU - Stockton, D. L. AU - Simpson, A. J. AU - Murchison, J. T. PY - 2009 DA - 2009// TI - Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy JO - Br J Cancer VL - 101 ID - Jones2009 ER - TY - JOUR AU - Kirwan, C. C. AU - McDowell, G. AU - McCollum, C. N. AU - Byrne, G. J. PY - 2011 DA - 2011// TI - Incidence of venous thromboembolism during chemotherapy for breast cancer: impact on cancer outcome JO - Anticancer Res VL - 31 ID - Kirwan2011 ER - TY - STD TI - BioRender, a web-based tool for life-science and medical illustration. Toronto, Canada. Available from: https://biorender.com/. Accessed 16 Apr 2020. UR - https://biorender.com/ ID - ref6 ER - TY - JOUR AU - Ahamed, J. AU - Versteeg, H. H. AU - Kerver, M. AU - Chen, V. M. AU - Mueller, B. M. AU - Hogg, P. J. PY - 2006 DA - 2006// TI - Disulfide isomerization switches tissue factor from coagulation to cell signaling JO - Proc Natl Acad Sci U S A VL - 103 ID - Ahamed2006 ER - TY - JOUR AU - Ruf, W. PY - 2012 DA - 2012// TI - Tissue factor and cancer JO - Thromb Res VL - 130 ID - Ruf2012 ER - TY - JOUR AU - Morris, D. R. AU - Ding, Y. AU - Ricks, T. K. AU - Gullapalli, A. AU - Wolfe, B. L. AU - Trejo, J. PY - 2006 DA - 2006// TI - Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells JO - Cancer Res VL - 66 ID - Morris2006 ER - TY - JOUR AU - Kasthuri, R. S. AU - Taubman, M. B. AU - Mackman, N. PY - 2009 DA - 2009// TI - Role of tissue factor in cancer JO - J Clin Oncol VL - 27 ID - Kasthuri2009 ER - TY - JOUR AU - Hjortoe, G. M. AU - Petersen, L. C. AU - Albrektsen, T. AU - Sorensen, B. B. AU - Norby, P. L. AU - Mandal, S. K. PY - 2004 DA - 2004// TI - Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration JO - Blood VL - 103 ID - Hjortoe2004 ER - TY - JOUR AU - Coughlin, S. R. PY - 2000 DA - 2000// TI - Thrombin signalling and protease-activated receptors JO - Nature VL - 407 ID - Coughlin2000 ER - TY - JOUR AU - Coughlin, S. R. PY - 2005 DA - 2005// TI - Protease-activated receptors in hemostasis, thrombosis and vascular biology JO - J Thromb Haemost VL - 3 ID - Coughlin2005 ER - TY - JOUR AU - Mosesson, M. W. PY - 2005 DA - 2005// TI - Fibrinogen and fibrin structure and functions JO - J Thromb Haemost VL - 3 ID - Mosesson2005 ER - TY - JOUR AU - Zain, J. AU - Huang, Y. Q. AU - Feng, X. AU - Nierodzik, M. L. AU - Li, J. J. AU - Karpatkin, S. PY - 2000 DA - 2000// TI - Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells JO - Blood VL - 95 ID - Zain2000 ER - TY - JOUR AU - Nierodzik, M. L. AU - Plotkin, A. AU - Kajumo, F. AU - Karpatkin, S. PY - 1991 DA - 1991// TI - Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo JO - J Clin Invest VL - 87 ID - Nierodzik1991 ER - TY - JOUR AU - Nierodzik, M. L. AU - Kajumo, F. AU - Karpatkin, S. PY - 1992 DA - 1992// TI - Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo JO - Cancer Res VL - 52 ID - Nierodzik1992 ER - TY - JOUR AU - Nierodzik, M. L. AU - Chen, K. AU - Takeshita, K. AU - Li, J. J. AU - Huang, Y. Q. AU - Feng, X. S. PY - 1998 DA - 1998// TI - Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis JO - Blood VL - 92 ID - Nierodzik1998 ER - TY - JOUR AU - Wojtukiewicz, M. Z. AU - Tang, D. G. AU - Nelson, K. K. AU - Walz, D. A. AU - Diglio, C. A. AU - Honn, K. V. PY - 1992 DA - 1992// TI - Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface JO - Thromb Res VL - 68 ID - Wojtukiewicz1992 ER - TY - JOUR AU - Klepfish, A. AU - Greco, M. A. AU - Karpatkin, S. PY - 1993 DA - 1993// TI - Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix JO - Int J Cancer VL - 53 ID - Klepfish1993 ER - TY - JOUR AU - Wojtukiewicz, M. Z. AU - Tang, D. G. AU - Ciarelli, J. J. AU - Nelson, K. K. AU - Walz, D. A. AU - Diglio, C. A. PY - 1993 DA - 1993// TI - Thrombin increases the metastatic potential of tumor cells JO - Int J Cancer VL - 54 ID - Wojtukiewicz1993 ER - TY - JOUR AU - Asanuma, K. AU - Wakabayashi, H. AU - Hayashi, T. AU - Okuyama, N. AU - Seto, M. AU - Matsumine, A. PY - 2004 DA - 2004// TI - Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis JO - Oncology VL - 67 ID - Asanuma2004 ER - TY - JOUR AU - Zhang, J. AU - Ding, J. AU - Zhang, X. AU - Shao, X. AU - Hao, Z. PY - 2005 DA - 2005// TI - Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue factor (TF) in SGC-7901 gastric cancer cells JO - Cancer Biol Ther VL - 4 ID - Zhang2005 ER - TY - JOUR AU - Liu, J. AU - Schuff-Werner, P. AU - Steiner, M. PY - 2006 DA - 2006// TI - Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells JO - Biochem Biophys Res Commun VL - 343 ID - Liu2006 ER - TY - JOUR AU - Karar, J. AU - Maity, A. PY - 2011 DA - 2011// TI - PI3K/AKT/mTOR pathway in angiogenesis JO - Front Mol Neurosci VL - 4 ID - Karar2011 ER - TY - JOUR AU - Yu, J. L. AU - May, L. AU - Lhotak, V. AU - Shahrzad, S. AU - Shirasawa, S. AU - Weitz, J. I. PY - 2005 DA - 2005// TI - Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis JO - Blood VL - 105 ID - Yu2005 ER - TY - JOUR AU - Maragoudakis, M. E. AU - Kraniti, N. AU - Giannopoulou, E. AU - Alexopoulos, K. AU - Matsoukas, J. PY - 2001 DA - 2001// TI - Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists JO - Endothelium VL - 8 ID - Maragoudakis2001 ER - TY - JOUR AU - Hinsbergh, V. W. AU - Collen, A. AU - Koolwijk, P. PY - 2001 DA - 2001// TI - Role of fibrin matrix in angiogenesis JO - Ann N Y Acad Sci VL - 936 ID - Hinsbergh2001 ER - TY - JOUR AU - Carneiro-Lobo, T. C. AU - Lima, M. T. AU - Mariano-Oliveira, A. AU - Dutra-Oliveira, A. AU - Oba-Shinjo, S. M. AU - Marie, S. K. PY - 2014 DA - 2014// TI - Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients JO - Oncol Rep VL - 31 ID - Carneiro-Lobo2014 ER - TY - JOUR AU - Wojtukiewicz, M. Z. AU - Rucinska, M. AU - Zimnoch, L. AU - Jaromin, J. AU - Piotrowski, Z. AU - Rozanska-Kudelska, M. PY - 2000 DA - 2000// TI - Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation JO - Thromb Res VL - 97 ID - Wojtukiewicz2000 ER - TY - JOUR AU - Wojtukiewicz, M. Z. AU - Sierko, E. AU - Zacharski, L. R. AU - Zimnoch, L. AU - Kudryk, B. AU - Kisiel, W. PY - 2003 DA - 2003// TI - Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer JO - Semin Thromb Hemost VL - 29 ID - Wojtukiewicz2003 ER - TY - JOUR AU - Rak, J. AU - Milsom, C. AU - May, L. AU - Klement, P. AU - Yu, J. PY - 2006 DA - 2006// TI - Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy JO - Semin Thromb Hemost VL - 32 ID - Rak2006 ER - TY - JOUR AU - Hu, L. AU - Lee, M. AU - Campbell, W. AU - Perez-Soler, R. AU - Karpatkin, S. PY - 2004 DA - 2004// TI - Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis JO - Blood VL - 104 ID - Hu2004 ER - TY - JOUR AU - Ueno, T. AU - Toi, M. AU - Koike, M. AU - Nakamura, S. AU - Tominaga, T. PY - 2000 DA - 2000// TI - Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration JO - Br J Cancer VL - 83 ID - Ueno2000 ER - TY - JOUR AU - Blackwell, K. AU - Haroon, Z. AU - Broadwater, G. AU - Berry, D. AU - Harris, L. AU - Iglehart, J. D. PY - 2000 DA - 2000// TI - Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status JO - J Clin Oncol VL - 18 ID - Blackwell2000 ER - TY - JOUR AU - Blackwell, K. L. AU - Dewhirst, M. W. AU - Liotcheva, V. AU - Snyder, S. AU - Broadwater, G. AU - Bentley, R. PY - 2004 DA - 2004// TI - HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors JO - Clin Cancer Res VL - 10 ID - Blackwell2004 ER - TY - JOUR AU - Mego, M. AU - Zuo, Z. AU - Gao, H. AU - Cohen, E. N. AU - Giordano, A. AU - Tin, S. PY - 2015 DA - 2015// TI - Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer JO - Thromb Haemost VL - 113 ID - Mego2015 ER - TY - STD TI - Kirwan CC, Descamps T, Castle J. Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer. Clin Transl Oncol. 2019;22(6):870–7. ID - ref38 ER - TY - JOUR AU - Batschauer, A. P. AU - Figueiredo, C. P. AU - Bueno, E. C. AU - Ribeiro, M. A. AU - Dusse, L. M. AU - Fernandes, A. P. PY - 2010 DA - 2010// TI - D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer JO - Ann Oncol VL - 21 ID - Batschauer2010 ER - TY - JOUR AU - Kirwan, C. C. AU - McCollum, C. N. AU - McDowell, G. AU - Byrne, G. J. PY - 2015 DA - 2015// TI - Investigation of proposed mechanisms of chemotherapy-induced venous thromboembolism: endothelial cell activation and procoagulant release due to apoptosis JO - Clin Appl Thromb Hemost VL - 21 ID - Kirwan2015 ER - TY - JOUR AU - Shaker, H. AU - Bundred, N. J. AU - Landberg, G. AU - Pritchard, S. A. AU - Albadry, H. AU - Nicholson, S. L. PY - 2020 DA - 2020// TI - Breast cancer stromal clotting activation (Tissue Factor and thrombin): a pre-invasive phenomena that is prognostic in invasion JO - Cancer Med VL - 9 ID - Shaker2020 ER - TY - STD TI - Akl EA, Gunukula S, Barba M, Yosuico VE, van Doormaal FF, Kuipers S, et al. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev. 2011;(4):CD006652. https://doi.org/10.1002/14651858.CD006652.pub3. ID - ref42 ER - TY - JOUR AU - Cohen, A. T. AU - Hamilton, M. AU - Bird, A. AU - Mitchell, S. A. AU - Li, S. AU - Horblyuk, R. PY - 2016 DA - 2016// TI - Comparison of the non-VKA oral anticoagulants apixaban, dabigatran, and rivaroxaban in the extended treatment and prevention of venous thromboembolism: systematic review and network meta-analysis JO - PLoS One VL - 11 ID - Cohen2016 ER - TY - JOUR AU - Lip, G. Y. AU - Mitchell, S. A. AU - Liu, X. AU - Liu, L. Z. AU - Phatak, H. AU - Kachroo, S. PY - 2016 DA - 2016// TI - Relative efficacy and safety of non-vitamin K oral anticoagulants for non-valvular atrial fibrillation: network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups JO - Int J Cardiol VL - 204 ID - Lip2016 ER - TY - JOUR AU - Vedovati, M. C. AU - Germini, F. AU - Agnelli, G. AU - Becattini, C. PY - 2015 DA - 2015// TI - Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis JO - Chest VL - 147 ID - Vedovati2015 ER - TY - JOUR AU - Roehrig, S. AU - Straub, A. AU - Pohlmann, J. AU - Lampe, T. AU - Pernerstorfer, J. AU - Schlemmer, K. H. PY - 2005 DA - 2005// TI - Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor JO - J Med Chem VL - 48 ID - Roehrig2005 ER - TY - JOUR AU - Kubitza, D. AU - Becka, M. AU - Voith, B. AU - Zuehlsdorf, M. AU - Wensing, G. PY - 2005 DA - 2005// TI - Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor JO - Clin Pharmacol Ther VL - 78 ID - Kubitza2005 ER - TY - JOUR AU - Kubitza, D. AU - Becka, M. AU - Wensing, G. AU - Voith, B. AU - Zuehlsdorf, M. PY - 2005 DA - 2005// TI - Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects JO - Eur J Clin Pharmacol VL - 61 ID - Kubitza2005 ER - TY - JOUR AU - Eriksson, B. I. AU - Borris, L. C. AU - Dahl, O. E. AU - Haas, S. AU - Huisman, M. V. AU - Kakkar, A. K. PY - 2006 DA - 2006// TI - A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement JO - Circulation VL - 114 ID - Eriksson2006 ER - TY - JOUR AU - Castle, J. AU - Farnie, G. AU - Kirwan, C. C. PY - 2016 DA - 2016// TI - PO-11 - Thrombin and cancer stem-like cells: in vitro support for breast cancer anticoagulation JO - Thromb Res VL - 140 ID - Castle2016 ER - TY - JOUR AU - Dowsett, M. AU - Smith, I. E. AU - Ebbs, S. R. AU - Dixon, J. M. AU - Skene, A. AU - Griffith, C. PY - 2005 DA - 2005// TI - Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival JO - Clin Cancer Res VL - 11 ID - Dowsett2005 ER - TY - STD TI - Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. The Royal College of Pathologists; 2016. https://www.rcpath.org/uploads/assets/7763be1c-d330-40e8-95d08f955752792a/G148_BreastDataset-hires-Jun16.pdf:. Accessed 17 Apr 2020. UR - https://www.rcpath.org/uploads/assets/7763be1c-d330-40e8-95d08f955752792a/G148_BreastDataset-hires-Jun16.pdf: ID - ref52 ER - TY - JOUR AU - Khoury, J. D. AU - Adcock, D. M. AU - Chan, F. AU - Symanowski, J. T. AU - Tiefenbacher, S. AU - Goodman, O. PY - 2010 DA - 2010// TI - Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer JO - Am J Clin Pathol VL - 134 ID - Khoury2010 ER - TY - JOUR AU - Saldanha, I. J. AU - Dickersin, K. AU - Wang, X. AU - Li, T. PY - 2014 DA - 2014// TI - Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability JO - PLoS One VL - 9 ID - Saldanha2014 ER - TY - JOUR AU - Shaw, F. L. AU - Harrison, H. AU - Spence, K. AU - Ablett, M. P. AU - Simoes, B. M. AU - Farnie, G. PY - 2012 DA - 2012// TI - A detailed mammosphere assay protocol for the quantification of breast stem cell activity JO - J Mammary Gland Biol Neoplasia VL - 17 ID - Shaw2012 ER - TY - JOUR AU - Ezzelle, J. AU - Rodriguez-Chavez, I. R. AU - Darden, J. M. AU - Stirewalt, M. AU - Kunwar, N. AU - Hitchcock, R. PY - 2008 DA - 2008// TI - Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories JO - J Pharm Biomed Anal VL - 46 ID - Ezzelle2008 ER - TY - JOUR AU - Dowsett, M. AU - A'Hern, R. AU - Bartlett, J. AU - Coombes, R. C. AU - Cuzick, J. PY - 2011 DA - 2011// TI - Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group JO - J Natl Cancer Inst VL - 103 ID - Dowsett2011 ER - TY - STD TI - National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Available from: https://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 22 July 2020. UR - https://evs.nci.nih.gov/ftp1/CTCAE/About.html ID - ref58 ER - TY - STD TI - (ICMJE) ICoMJE. Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly work in Medical Journals. Available from: http://icmje.org/recommendations. Accessed 22 July 2020. UR - http://icmje.org/recommendations ID - ref59 ER - TY - STD TI - National Institute for Clinical Excellence (NICE) Rivaroxaban Indications and Dose. Available from: https://bnf.nice.org.uk/drug/rivaroxaban.html#indicationsAndDoses. Accessed 11 July 2019. UR - https://bnf.nice.org.uk/drug/rivaroxaban.html#indicationsAndDoses ID - ref60 ER - TY - JOUR AU - Lai, A. AU - Davidson, N. AU - Galloway, S. W. AU - Thachil, J. PY - 2014 DA - 2014// TI - Perioperative management of patients on new oral anticoagulants JO - Br J Surg VL - 101 ID - Lai2014 ER -